Ling Jiang

3.6k total citations · 1 hit paper
76 papers, 2.5k citations indexed

About

Ling Jiang is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Ling Jiang has authored 76 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 11 papers in Nephrology and 11 papers in Cancer Research. Recurrent topics in Ling Jiang's work include Chronic Kidney Disease and Diabetes (9 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ling Jiang is often cited by papers focused on Chronic Kidney Disease and Diabetes (9 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ling Jiang collaborates with scholars based in China, United States and Hong Kong. Ling Jiang's co-authors include Tianlu Shi, Lei Zhang, Pengli Zhu, Cheng Huang, Xue‐qi Liu, Yonggui Wu, Jun Li, D Mingying, Tingting Hu and Zhaolin Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLANT PHYSIOLOGY and Scientific Reports.

In The Last Decade

Ling Jiang

70 papers receiving 2.5k citations

Hit Papers

Mammalian drug efflux transporters of the ATP binding cas... 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Jiang China 25 1.4k 426 379 316 268 76 2.5k
Ping Zhao China 28 1.5k 1.1× 465 1.1× 220 0.6× 167 0.5× 309 1.2× 147 2.9k
Weijia Zhang China 30 1.3k 1.0× 345 0.8× 251 0.7× 388 1.2× 98 0.4× 70 2.9k
Taotao Ma China 33 1.6k 1.2× 298 0.7× 691 1.8× 332 1.1× 235 0.9× 79 2.9k
Myeong‐Sok Lee South Korea 26 1.2k 0.9× 239 0.6× 272 0.7× 129 0.4× 154 0.6× 83 2.1k
Na Jiang China 23 861 0.6× 167 0.4× 376 1.0× 170 0.5× 242 0.9× 96 2.1k
Jie Su China 26 1.1k 0.8× 292 0.7× 246 0.6× 98 0.3× 125 0.5× 133 2.1k
Dong‐Yun Ouyang China 33 1.9k 1.4× 218 0.5× 218 0.6× 266 0.8× 194 0.7× 82 2.8k
Mahaboobkhan Rasool India 36 1.2k 0.9× 236 0.6× 273 0.7× 300 0.9× 80 0.3× 109 3.4k
Zhifeng Wei China 33 1.5k 1.1× 295 0.7× 376 1.0× 72 0.2× 255 1.0× 131 3.0k
Yuanyuan Wu China 27 1.1k 0.8× 299 0.7× 340 0.9× 64 0.2× 137 0.5× 116 2.2k

Countries citing papers authored by Ling Jiang

Since Specialization
Citations

This map shows the geographic impact of Ling Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Jiang more than expected).

Fields of papers citing papers by Ling Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Jiang. The network helps show where Ling Jiang may publish in the future.

Co-authorship network of co-authors of Ling Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Jiang. A scholar is included among the top collaborators of Ling Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Jiang. Ling Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Jiang, Ling, et al.. (2024). Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis. International Immunopharmacology. 130. 111790–111790. 6 indexed citations
4.
Jiang, Ling, Ka Yan Ho, Katherine Ka Wai Lam, et al.. (2024). Spiritual Interventions Among Pediatric Patients With Cancer: A Systematic Review And Meta-Analysis. Journal of Pain and Symptom Management. 68(1). e8–e20. 2 indexed citations
5.
Qiu, Lihua, et al.. (2023). Systematic analysis of cuproptosis-related genes in immunological characterization and predictive drugs in Alzheimer’s disease. Frontiers in Aging Neuroscience. 15. 1204530–1204530. 4 indexed citations
6.
Liu, Xueqi, Mengya Zhang, Lang Zhou, et al.. (2023). Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting Slc7a11-mediated ferroptosis. International Immunopharmacology. 116. 109754–109754. 32 indexed citations
7.
Zhang, Siliang, Aixia Chen, Ling Jiang, Xiaoli Liu, & Lihong Chai. (2023). Copper-mediated shifts in transcriptomic responses of intestines in Bufo gargarizans tadpoles to lead stress. Environmental Science and Pollution Research. 30(17). 50144–50161. 2 indexed citations
8.
Jiang, Ling, Xue‐qi Liu, Li Gao, et al.. (2022). METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular Therapy. 30(4). 1721–1740. 135 indexed citations
9.
Huang, Yuebo, Ling Jiang, Xue‐qi Liu, et al.. (2022). Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis‐Mediated Ferroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 4776243–4776243. 51 indexed citations
10.
Chai, Lihong, et al.. (2022). Effects of waterborne Pb/Cu mixture on Chinese toad, Bufo gargarizans tadpoles: morphological, histological, and intestinal microbiota assessment. Environmental Science and Pollution Research. 29(60). 90656–90670. 15 indexed citations
11.
Wang, Xian, et al.. (2022). Clinical Significance of Glomerular Autophagy in Evaluation of Diabetic Kidney Disease Progression. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1945–1959. 9 indexed citations
12.
Wang, Anli, et al.. (2022). Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db/db mice. International Immunopharmacology. 109. 108792–108792. 21 indexed citations
13.
Li, Yuanyuan, Han-xu Zeng, Xue‐qi Liu, et al.. (2021). Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis. International Immunopharmacology. 101(Pt B). 108236–108236. 44 indexed citations
14.
Yang, Qin, Haiyong Chen, Jianan Wang, et al.. (2020). Alcohol promotes renal fibrosis by activating Nox2/4-mediated DNA methylation of Smad7. Clinical Science. 134(2). 103–122. 26 indexed citations
15.
Yang, Hui, et al.. (2020). Quantitative DCE-MRI: an efficient diagnostic technique for evaluating early micro-environment permeability changes in ankylosing spondylitis. BMC Musculoskeletal Disorders. 21(1). 774–774. 1 indexed citations
16.
Wang, Jianan, Mingming Liu, Fang Wang, et al.. (2019). RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress. Clinical Science. 133(14). 1609–1627. 67 indexed citations
17.
Chen, Zhaolin, Cheng Huang, Taotao Ma, et al.. (2018). Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells. Phytomedicine. 43. 37–45. 90 indexed citations
18.
Chen, Zhaolin, Tianlu Shi, Lei Zhang, et al.. (2015). Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Letters. 370(1). 153–164. 633 indexed citations breakdown →
19.
Wang, Lin, et al.. (2014). Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis. International Journal of Neuroscience. 125(5). 328–335. 6 indexed citations
20.
Chen, Tianbin, Qicai Liu, Ling Jiang, Can Liu, & Qishui Ou. (2012). Mitochondrial COX2 G7598A Mutation May Have a Modifying Role in the Phenotypic Manifestation of Aminoglycoside Antibiotic-Induced Deafness Associated with 12S rRNA A1555G Mutation in a Han Chinese Pedigree. Genetic Testing and Molecular Biomarkers. 17(2). 122–130. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026